Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
- Author
- CHINOT, Olivier L1 ; WICK, Wolfgang5 ; BRANDES, Alba A13 ; HILTON, Magalie14 ; ABREY, Lauren14 ; CLOUGHESY, Timothy15 ; MASON, Warren6 ; HENRIKSSON, Roger8 9 ; SARAN, Frank10 ; NISHIKAWA, Ryo11 ; CARPENTIER, Antoine F2 3 ; HOANG-XUAN, Khe4 ; KAVAN, Petr7 ; CERNEA, Dana12
[1] Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Service de Neuro-Oncologie, Centre Hospitaliere Universitaire Timone, Marseille, France
[2] UFR de Santé, Médecine et Biologie Humaine, Bobigny, France
[3] Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Avicenne, Service de Neurologie, Université Paris 13, France
[4] AP-HP, Université Pierre-et-Marie-Curie, Group Hospitalier Pitié-Salpêtrière, Paris, France
[5] University Hospital of Heidelberg, Department of Neurooncology, and German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany
[6] Princess Margaret Hospital, Toronto, Canada
[7] McGill University, Montreal, Canada
[8] Regional Cancer Center, Stockholm Gotland, Karolinska, Stockholm, Sweden
[9] Department of Radiation Sciences and Oncology, Umeå University, Umeå, Sweden
[10] Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, United Kingdom
[11] Saitama Medical University, Saitama, Japan
[12] Oncology Institute Ion Chiricuta, Cluj-Napoca, Romania
[13] Medical Oncology Department, Azienda Unità Sanitaria Locale, Bologna, Italy
[14] F. Hoffmann-La Roche, Basel, Switzerland
[15] University of California, Los Angeles, Los Angeles, United States - Source
The New England journal of medicine. 2014, Vol 370, Num 8, pp 709-722, 14 p ; ref : 41 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Scientific domain
- General medicine general surgery
- Publisher
- Massachusetts Medical Society, Waltham, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antiangiogénique Anticancéreux Association médicamenteuse Bévacizumab Diagnostic Facteur croissance endothélium vasculaire Glioblastome Immunomodulateur Médecine Radiothérapie Traitement Témozolomide Anti-VEGF Agent alkylant Anticorps monoclonal Cancer Gliome malin Pathologie du système nerveux central Pathologie du système nerveux Tumeur maligne
- Keyword (en)
- Antiangiogenic agent Antineoplastic agent Drug combination Bevacizumab Diagnosis Vascular endothelium growth factor Glioblastoma Immunomodulator Medicine Radiotherapy Treatment Temozolomide Alkylating agent Monoclonal antibody Cancer Malignant glioma Central nervous system disease Nervous system diseases Malignant tumor
- Keyword (es)
- Antiangiogenico Anticanceroso Asociación medicamentosa Bevacizumab Diagnóstico Factor crecimiento endotelio vascular Glioblastoma Inmunomodulador Medicina Radioterapia Tratamiento Temozolomida Agente alquilante Anticuerpo monoclonal Cáncer Glioma maligno Sistema nervosio central patología Sistema nervioso patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02Q Immunomodulators
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17E Tumors of the nervous system. Phacomatoses
- Discipline
- Generalities in medical sciences Neurology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 28149272
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1056/NEJMoa1308345 
https://dx.doi.org/10.1056/NEJMoa1308345
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1308345\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"709\";s:8:\"\u0000*\u0000epage\";s:3:\"722\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"CHINOT\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Olivier L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:14:\"WICK, Wolfgang\";i:1;s:15:\"BRANDES, Alba A\";i:2;s:15:\"HILTON, Magalie\";i:3;s:13:\"ABREY, Lauren\";i:4;s:18:\"CLOUGHESY, Timothy\";i:5;s:13:\"MASON, Warren\";i:6;s:17:\"HENRIKSSON, Roger\";i:7;s:12:\"SARAN, Frank\";i:8;s:14:\"NISHIKAWA, Ryo\";i:9;s:21:\"CARPENTIER, Antoine F\";i:10;s:15:\"HOANG-XUAN, Khe\";i:11;s:11:\"KAVAN, Petr\";i:12;s:12:\"CERNEA, Dana\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"14\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1308345\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"709\";s:8:\"\u0000*\u0000epage\";s:3:\"722\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"CHINOT\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Olivier L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:14:\"WICK, Wolfgang\";i:1;s:15:\"BRANDES, Alba A\";i:2;s:15:\"HILTON, Magalie\";i:3;s:13:\"ABREY, Lauren\";i:4;s:18:\"CLOUGHESY, Timothy\";i:5;s:13:\"MASON, Warren\";i:6;s:17:\"HENRIKSSON, Roger\";i:7;s:12:\"SARAN, Frank\";i:8;s:14:\"NISHIKAWA, Ryo\";i:9;s:21:\"CARPENTIER, Antoine F\";i:10;s:15:\"HOANG-XUAN, Khe\";i:11;s:11:\"KAVAN, Petr\";i:12;s:12:\"CERNEA, Dana\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"14\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1308345\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1308345\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"709\";s:8:\"\u0000*\u0000epage\";s:3:\"722\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"CHINOT\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Olivier L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:14:\"WICK, Wolfgang\";i:1;s:15:\"BRANDES, Alba A\";i:2;s:15:\"HILTON, Magalie\";i:3;s:13:\"ABREY, Lauren\";i:4;s:18:\"CLOUGHESY, Timothy\";i:5;s:13:\"MASON, Warren\";i:6;s:17:\"HENRIKSSON, Roger\";i:7;s:12:\"SARAN, Frank\";i:8;s:14:\"NISHIKAWA, Ryo\";i:9;s:21:\"CARPENTIER, Antoine F\";i:10;s:15:\"HOANG-XUAN, Khe\";i:11;s:11:\"KAVAN, Petr\";i:12;s:12:\"CERNEA, Dana\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"14\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1308345\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"709\";s:8:\"\u0000*\u0000epage\";s:3:\"722\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"CHINOT\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Olivier L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:14:\"WICK, Wolfgang\";i:1;s:15:\"BRANDES, Alba A\";i:2;s:15:\"HILTON, Magalie\";i:3;s:13:\"ABREY, Lauren\";i:4;s:18:\"CLOUGHESY, Timothy\";i:5;s:13:\"MASON, Warren\";i:6;s:17:\"HENRIKSSON, Roger\";i:7;s:12:\"SARAN, Frank\";i:8;s:14:\"NISHIKAWA, Ryo\";i:9;s:21:\"CARPENTIER, Antoine F\";i:10;s:15:\"HOANG-XUAN, Khe\";i:11;s:11:\"KAVAN, Petr\";i:12;s:12:\"CERNEA, Dana\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"14\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1308345\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"709\";s:8:\"\u0000*\u0000epage\";s:3:\"722\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"CHINOT\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Olivier L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:14:\"WICK, Wolfgang\";i:1;s:15:\"BRANDES, Alba A\";i:2;s:15:\"HILTON, Magalie\";i:3;s:13:\"ABREY, Lauren\";i:4;s:18:\"CLOUGHESY, Timothy\";i:5;s:13:\"MASON, Warren\";i:6;s:17:\"HENRIKSSON, Roger\";i:7;s:12:\"SARAN, Frank\";i:8;s:14:\"NISHIKAWA, Ryo\";i:9;s:21:\"CARPENTIER, Antoine F\";i:10;s:15:\"HOANG-XUAN, Khe\";i:11;s:11:\"KAVAN, Petr\";i:12;s:12:\"CERNEA, Dana\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"14\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
